DC-Vac/EP-L (Binex)

N/A

Report date: 2023/01/08 19:06:31

Base Information

Drug NameDC-Vac/EP-L (Binex)

Drug Alias NameDC-Vac/EP-L

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesBinex

China Registration ClassN/A

Develop Information

Active CompaniesBinex

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A